Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sarah Parackal

3PUBLICATIONS
48CO-AUTHORS
Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|May 05, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|Oct 23, 2021
Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy.

Wai C Chong, W Samantha N Jayasekara, Vijesh G Vaghjiani

Pageof 1

Frequent Collaborators

3 joint publications

Jason E Cain

2 joint publications

Matthew D Dun

2 joint publications

Evangeline R Jackson

2 joint publications

Ryan J Duchatel

2 joint publications

Dilana E Staudt

2 joint publications

Mika L Persson

2 joint publications

Abdul Mannan

2 joint publications

Sridevi Yadavilli

2 joint publications

Shaye Game

2 joint publications

Wai Chin Chong

Frequent Collaborators

3 joint publications

Jason E Cain

2 joint publications

Matthew D Dun

2 joint publications

Evangeline R Jackson

2 joint publications

Ryan J Duchatel

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.4K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.4K
See more related videos